Exciting news from #DGI_DZIF_AnnualMeeting!
Huge congratulations to Ecem Sekban for winning the Poster Award! 🏆🎊
Also big shoutout to our lab members for their fantastic poster presentations!👏
Your hard work and dedication continue to push science forward! 🚀🔬#TeamScience
Our new research reveals SARS-CoV-2 doesn't just stop at the lungs—it infects liver cells, replicates, and induces cell death. A deeper dive into the virus's stealthy tactics and its role in liver damage during COVID-19. #Virology#COVID19Research 🦠🧪🧑🔬
onlinelibrary.wiley.com/doi/…
Explore how bispecific T-cell engager antibodies revolutionize chronic hepatitis B treatment by activating adaptive immunity. Read about the promising strategy in the fight against HBV in our latest review by @zhexie97 and @UlrikeProtzer!
sciencedirect.com/science/ar…
NTCP is a limiting factor for HBV infection in porcine hepatocytes, with amino acids 158 and 167 in porcine NTCP inhibiting the interaction with the virus. These findings pave the way for the development of transgenic pigs as new models for HBV research 🎉🍾
‼️‼️Did you see our latest publication in @Nature_NPJ ?
“Identification of amino acids restricting HBV receptor function in porcine NTCP”
Check it out! ⬇️⬇️
nature.com/articles/s44298-0…
Do not miss the Best Poster Presentation Award winner at #EASLCongress 2024! 🏆Come and visit Zhe Xie’s incredible work in the poster area TOP-355-YI! 🤩🎉👏🏻👍
Today is our day! An outstanding talk was given by Dr.Anna Kosinska at #EASLCongress 2024 in the general session! She delivered a talk about combinatiorial treatment of siRNAs with our clinical therapeutic vaccine candidate #TherVacB against chronic hepatitis B! 🎉🤩👏🏻
Today Dr.Sophia Schreiber delivered an outstanding talk at #EASLCongress 2024 in the liver immunology session, discussing the combination of TCR-redirected CD4 and CD8 T cells in the T-cell therapy for HBV infection! 🎉👏🏻
We will be in #EASLCongress 2024 with two amazing talks and two posters! If you want to learn more about our HBV research, visit our posters and come to talks on Friday will be given bu Dr. Anna Kosinska and Dr. Sophia Schreiber!
🚨🚨
Our latest work out now in Antiviral Research!
Key highlights -
🔹Novel HBV-carrier mouse model lacking HBsAg secretion
🔹Lack of HBsAg secretion did not affect viral persistence and T-cell responses or influence efficacy of therapeutic vaccine
sciencedirect.com/science/ar…
🚨🚨🚨
Now out in @FrontImmunol -
Our novel HBV-specific CARs derived from broadly neutralizing, human monoclonal antibodies identified by single B cell sorting are able to kill HBV-positive cells and are functional in vivo!
A step towards targeted immunotherapies!
Link👇🏻
🚨 PAPER ALERT 🚨
We are delighted to announce that our most recent paper on “Introducing adjuvant-loaded particulate hepatitis B core antigen as an alternative therapeutic hepatitis B vaccine component” is out now online in @JHEP_Reports 🎉 link is ⬇️
jhep-reports.eu/article/S258…
The final day of #HBVMeeting2023! Departing from Kobe with a treasure trove of science, joy, and the satisfaction of connecting with brilliant minds. See you next year in Chicago for more scientific adventures! 👩🔬🧑🔬🔬🇺🇸🇯🇵🇩🇪
We are closing the sessions with incredible talks at #HBVMeeting2023 in Kobe! Featuring Dr. Anna Kosinska, Edanur Ates Öz, and Dr. Ulrike Protzer, shedding light on HBV research. 👩🔬🌄
Good morning from Day 3 of #HBVMeeting2023 from Kobe! 🌄🌞 Today kicks off with Edanur Ates Öz's (@mintandyogurt ) oral presentation, and we'll wrap up with the amazing posters from our lab during the poster sessions. Let's continue the journey of knowledge and discovery👩🔬🧑🔬🦠!
Day 2 at #HBVMeeting in Kobe promises excitement! Dr. Anna Kosinska's talk about #TherVacB in Session IV, followed by an amazing poster presentation from our group. Get ready for a day of insights and discoveries! 🌄👩🔬🧑🔬